Accurate, Focused Research on Law, Technology and Knowledge Discovery With Daily Postings Since 2002
Katherine Eban – investigative journalist, Vanity Fair contributor and Andrew Carnegie fellow (also see her TEDMED Talk here). “A: Typically, the manufacturer name will be listed on the pill bottle’s dispensing label. However, this isn’t always the case. If you can’t find the name of the manufacturer on the packaging, call your pharmacist and ask …
Lifehacker: “…Experts agree the government is highly unlikely to mandate civilians get a COVID vaccination. So how do we get enough people to take it to functionally end the pandemic? A least 70 percent of the population will likely need get the vaccine before we reach herd immunity, the point at which person-to-person spread becomes …
KFF: “On December 1, 2020, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention’s (CDC), issued an initial recommendation, adopted by the CDC director, that health care personnel and residents of long-term care facilities should be the first to be offered a COVID-19 vaccine once it is authorized or …
Vox – The Covid-19 vaccine requires two doses. Studies show as many as 50 percent of people could miss the second one. “When we talk about the Covid-19 vaccines, we aren’t necessarily talking about people getting one shot, then being done and good to go. Both the Pfizer and Moderna vaccines — which are the …
LA Times [paywall / Free via Yahoo News]: ” Dr. Lee Ju-hyung has largely avoided restaurants in recent months, but on the few occasions he’s dined out, he’s developed a strange, if sensible, habit: whipping out a small anemometer to check the airflow. It’s a precaution he has been taking since a June experiment in …
The New York Times – “The new Covid-19 vaccines from Pfizer and Moderna seem to be remarkably good at preventing serious illness. But it’s unclear how well they will curb the spread of the coronavirus. That’s because the Pfizer and Moderna trials tracked only how many vaccinated people became sick with Covid-19. That leaves open …
Vaccines and Related Biological Products Advisory Committee Meeting – December 10, 2020 – FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine: “On November 20, 2020, Pfizer and BioNTech (the Sponsor) submitted an Emergency Use Authorization (EUA) request to FDA for an investigational COVID-19 vaccine (BNT162b2) intended to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 …
The New York Times – “A vaccine may be around the corner, but how long will it be until you get the shot? Health officials are considering vaccine timelines that give some Americans priority over others. If you’re a healthy American, you may wait many months for your turn. To put this in perspective, we …
ZDNet – “Vaccines to block COVID-19 that are in development by Moderna, Pfizer, AstraZeneca and others, and that are currently in Phase III clinical trials, may not do as well covering people of Black or Asian genetic ancestry as they do for white people, a study released Wednesday by the Massachusetts Institute of Technology indicated. …
CRS report via LC – Legal Issues in COVID-19 Vaccine Development and Deployment, Updated November 25, 2020 – “Private companies, universities, and governmental entities are working to develop a vaccine for coronavirus disease 2019 (COVID-19). Vaccines are biological products regulated under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act (FD&C …
Highline – HuffPo – “This is an accounting of the damage…The administration has failed on so many different fronts in its handling of the coronavirus, creating the overall impression of sheer mayhem. But there is a common thread that runs through these government malfunctions. Precise, transparent data is crucial in the fight against a pandemic—yet …
Science Magazine: “Across the United States, COVID-19 wards like this one at University of Wisconsin Health in Madison are filling up fast, but federal data on their patient numbers and available beds are suspect, which could hinder getting personal protective equipment, other supplies, or medicines to where they are needed most…HHS Protect’s problems are a national issue, …
